1XRAY Stock Chart & Stats
€9.58
€0.07(0.56%)
At close: 4:00 PM EDT
€9.58
€0.07(0.56%)
Day’s Range― - ―
52-Week Range€5.00 - €18.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€1.54B
Enterprise Value€4.20B
Total Cash (Recent Filing)€239.00M
Total Debt (Recent Filing)€2.31B
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Oct 29, 2026EPS Estimate
0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.74
Shares Outstanding199,353,880
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)1.70
Price to Sales (P/S)0.62
P/FCF Ratio21.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€11.66Price Target Upside21.68% Upside
Rating ConsensusHold
Number of Analyst Covering11
EPS Forecast (FY)1.34
Revenue Forecast (FY)€3.14B
Bulls Say, Bears Say
Bulls Say
Diversified Recurring Dental ModelDentsply Sirona combines repeat-purchase consumables with equipment, implants, software and services across multiple dental disciplines. This breadth can diversify demand, support customer relationships, and create follow-on revenue from its installed equipment base over the coming quarters.
Positive Cash GenerationPositive operating cash flow in every period shown and TTM free cash flow of about $131 million provide internal funding while the business works through its turnaround. Cash generation supports investment in sales, education and R&D and offers some resilience despite reported losses.
Wellspect And Digital Product MomentumGrowth at Wellspect, supported by product launches and geographic expansion, demonstrates that parts of the portfolio can gain traction despite broader pressure. Adoption of DS Core by European DSO groups also strengthens the company’s digital ecosystem and future recurring engagement.
Bears Say
Persistent Revenue Decline And LossesThe multi-year revenue contraction and continuing negative TTM net margin indicate that the turnaround has not yet restored durable earnings power. Ongoing losses reduce retained capital, limit financial flexibility, and make future growth investments more dependent on successful execution.
Elevated Leverage Limits FlexibilityDebt materially exceeds equity and leverage is higher than in 2021–2023, while returns on equity remain negative. This combination can constrain capital allocation, increase pressure to prioritize debt service, and reduce the company’s ability to absorb prolonged operating weakness.
Cyclical Exposure To Clinic InvestmentThe company’s higher-ticket imaging, CAD/CAM and treatment-center products depend partly on dental-clinic investment decisions rather than routine replenishment. That cyclical exposure can make revenue less predictable and amplify weakness when customers defer equipment purchases.
DENTSPLY SIRONA News
1XRAY FAQ
What was DENTSPLY SIRONA Inc’s price range in the past 12 months?
DENTSPLY SIRONA Inc lowest stock price was €5.00 and its highest was €18.00 in the past 12 months.
What is DENTSPLY SIRONA Inc’s market cap?
DENTSPLY SIRONA Inc’s market cap is €1.54B.
When is DENTSPLY SIRONA Inc’s upcoming earnings report date?
DENTSPLY SIRONA Inc’s upcoming earnings report date is Oct 29, 2026 which is in 24 days.
How were DENTSPLY SIRONA Inc’s earnings last quarter?
DENTSPLY SIRONA Inc released its earnings results on Aug 06, 2026. The company reported €0.463 earnings per share for the quarter, beating the consensus estimate of €0.31 by €0.153.
Is DENTSPLY SIRONA Inc overvalued?
According to Wall Street analysts DENTSPLY SIRONA Inc’s price is currently Undervalued.
Does DENTSPLY SIRONA Inc pay dividends?
DENTSPLY SIRONA Inc does not currently pay dividends.
What is DENTSPLY SIRONA Inc’s EPS estimate?
DENTSPLY SIRONA Inc’s EPS estimate is 0.28.
How many shares outstanding does DENTSPLY SIRONA Inc have?
DENTSPLY SIRONA Inc has 199,353,880 shares outstanding.
What happened to DENTSPLY SIRONA Inc’s price movement after its last earnings report?
DENTSPLY SIRONA Inc reported an EPS of €0.463 in its last earnings report, beating expectations of €0.31. Following the earnings report the stock price went down -10.533%.
Which hedge fund is a major shareholder of DENTSPLY SIRONA Inc?
Currently, no hedge funds are holding shares in IT:1XRAY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DENTSPLY SIRONA Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€11.66 (21.68% Upside)
€11.66 (21.68% Upside)
Blogger Sentiment
Neutral
IT:1XRAY Sentiment 83%
Sector Average 65%
Sector Average 65%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.13%
12-Months-Change
Fundamentals
Return on Equity
6.90%
Trailing 12-Months
Asset Growth
-14.25%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
1XRAY Company Deck
1XRAY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call reflected a mixed but constructive tone: management reported near-term top-line pressures across multiple segments (notably OIS and consumables distributor headwinds in EMEA) and acknowledged tariff and geopolitical uncertainties. Offsetting these challenges were stable adjusted EBITDA and EPS, a one-time $44 million tariff refund that materially improved cash flow and EPS, continued strategic investments in sales, clinical education and R&D, expansion of dealer partnerships, and strong Wellspect performance. Management maintained full-year guidance and emphasized that improvements from the return-to-growth action plan should become more visible in Q4 and into 2027. Given balanced operational progress and strategic momentum against ongoing revenue and regional demand headwinds, the overall message is cautiously optimistic but still in turnaround mode.View all IT:1XRAY earnings summaries1XRAY Net sales Breakdown
15.71% Equipment & Instruments
12.45% CAD/CAM
39.92% Essential Dental Solutions
6.17% Orthodontics
16.93% Implants & Prosthetics
8.83% Wellspect Healthcare
1XRAY Stock 12 Month Forecast
Average Price Target
€11.66
▲(21.68% Upside)